Stocks and Investing Stocks and Investing
Fri, January 20, 2023

Michael Petusky Maintained (SRDX) at Buy with Decreased Target to $61 on, Jan 20th, 2023


Published on 2024-10-28 01:00:45 - WOPRAI, Michael Petusky
  Print publication without navigation


Michael Petusky of Barrington Research, Maintained "Surmodics, Inc." (SRDX) at Buy with Decreased Target from $70 to $61 on, Jan 20th, 2023.

Michael, nor any peers, have made any analyst calls on SRDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources